Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Nanoscale Mixed-Ligand Metal-Organic Framework for X-ray Stimulated Cancer Therapy.
Response of human prostate cancer cells and tumors to combining PARP inhibition with ionizing radiation.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Nanoscale Mixed-Ligand Metal-Organic Framework for X-ray Stimulated Cancer Therapy.
Nanoscale Mixed-Ligand Metal-Organic Framework for X-ray Stimulated Cancer Therapy. J Am Chem Soc. 2024 Dec 04; 146(48):33149-33158.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Cell Line, Tumor
Humans
Ligands
Metal-Organic Frameworks
Mice
X-Rays
authors with profiles
Ralph R. Weichselbaum